173 related articles for article (PubMed ID: 36499426)
1. Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through ERK1/2/β-Catenin Pathway in Human Cervical Cancer Cell Lines.
Hsin MC; Hsiao YH; Chen PN; Lin CW; Wang PH; Yang SF; Lee CY
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499426
[TBL] [Abstract][Full Text] [Related]
2. Dihydromyricetin inhibits cancer cell migration and matrix metalloproteinases-2 expression in human nasopharyngeal carcinoma through extracellular signal-regulated kinase signaling pathway.
Huang CC; Su CW; Wang PH; Lu YT; Ho YT; Yang SF; Hsin CH; Lin CW
Environ Toxicol; 2022 May; 37(5):1244-1253. PubMed ID: 35112788
[TBL] [Abstract][Full Text] [Related]
3. Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.
Zhang QY; Li R; Zeng GF; Liu B; Liu J; Shu Y; Liu ZK; Qiu ZD; Wang DJ; Miao HL; Li MY; Zhu RZ
World J Gastroenterol; 2014 Aug; 20(29):10082-93. PubMed ID: 25110435
[TBL] [Abstract][Full Text] [Related]
4. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
[TBL] [Abstract][Full Text] [Related]
5. Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-κB-modulated urokinase plasminogen activator inhibition.
Chou CH; Lu KH; Yang JS; Hsieh YH; Lin CW; Yang SF
Phytomedicine; 2021 Sep; 90():153642. PubMed ID: 34265701
[TBL] [Abstract][Full Text] [Related]
6. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
[TBL] [Abstract][Full Text] [Related]
7. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway.
Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I
Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844
[TBL] [Abstract][Full Text] [Related]
8. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
Rao Y; Wang H; Fan L; Chen G
J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
[TBL] [Abstract][Full Text] [Related]
9. Effects of dihydromyricetin on ARPE-19 cell migration through regulating matrix metalloproteinase-2 expression.
Wang K; Yang SF; Hsieh YH; Chang YY; Yu NY; Lin HW; Lin HY
Environ Toxicol; 2018 Dec; 33(12):1298-1303. PubMed ID: 30259634
[TBL] [Abstract][Full Text] [Related]
10. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
Wang XG; Meng Q; Qi FM; Yang QF
Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis.
Kortüm B; Radhakrishnan H; Zincke F; Sachse C; Burock S; Keilholz U; Dahlmann M; Walther W; Dittmar G; Kobelt D; Stein U
Oncogene; 2022 Sep; 41(39):4446-4458. PubMed ID: 36008464
[TBL] [Abstract][Full Text] [Related]
12. Golgi reassembly and stacking protein 65 downregulation is required for the anti-cancer effect of dihydromyricetin on human ovarian cancer cells.
Wang F; Chen X; Yuan D; Yi Y; Luo Y
PLoS One; 2019; 14(11):e0225450. PubMed ID: 31770410
[TBL] [Abstract][Full Text] [Related]
13. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
[TBL] [Abstract][Full Text] [Related]
14. S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition.
Hou S; Tian T; Qi D; Sun K; Yuan Q; Wang Z; Qin Z; Wu Z; Chen Z; Zhang J
Cell Death Dis; 2018 Feb; 9(3):277. PubMed ID: 29449540
[TBL] [Abstract][Full Text] [Related]
15. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
Sack U; Walther W; Scudiero D; Selby M; Aumann J; Lemos C; Fichtner I; Schlag PM; Shoemaker RH; Stein U
Mol Biol Cell; 2011 Sep; 22(18):3344-54. PubMed ID: 21795396
[TBL] [Abstract][Full Text] [Related]
16. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
17. [Effects of dihydromyricetin on the migration and invasion of human gastric cancer MKN45 cells and its mechanism].
Wang FJ; Zong XY; DU JL; Wang WS; Yuan DP; Chen XB
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Sep; 35(5):428-432. PubMed ID: 31894675
[TBL] [Abstract][Full Text] [Related]
18. Arctiin Inhibits Cervical Cancer Cell Migration and Invasion through Suppression of S100A4 Expression via PI3K/Akt Pathway.
Lee CY; Hsin MC; Chen PN; Lin CW; Wang PH; Yang SF; Hsiao YH
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214097
[TBL] [Abstract][Full Text] [Related]
19. Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells.
Jiang L; Ye WC; Li Z; Yang Y; Dai W; Li M
BMC Complement Med Ther; 2021 Jul; 21(1):194. PubMed ID: 34229692
[TBL] [Abstract][Full Text] [Related]
20. Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway.
Lan K; Zhao Y; Fan Y; Ma B; Yang S; Liu Q; Linghu H; Wang H
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
